Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Current Assets (2023 - 2025)

Camp4 Therapeutics' Current Assets history spans 3 years, with the latest figure at $114.1 million for Q4 2025.

  • For Q4 2025, Current Assets rose 71.87% year-over-year to $114.1 million; the TTM value through Dec 2025 reached $114.1 million, up 71.87%, while the annual FY2025 figure was $114.1 million, 71.87% up from the prior year.
  • Current Assets for Q4 2025 was $114.1 million at Camp4 Therapeutics, up from $51.7 million in the prior quarter.
  • Across five years, Current Assets topped out at $114.1 million in Q4 2025 and bottomed at $5.5 million in Q3 2024.
  • The 3-year median for Current Assets is $51.7 million (2025), against an average of $55.5 million.
  • The largest annual shift saw Current Assets skyrocketed 65.9% in 2024 before it skyrocketed 71.87% in 2025.
  • A 3-year view of Current Assets shows it stood at $40.0 million in 2023, then surged by 65.9% to $66.4 million in 2024, then surged by 71.87% to $114.1 million in 2025.
  • Per Business Quant, the three most recent readings for CAMP's Current Assets are $114.1 million (Q4 2025), $51.7 million (Q1 2025), and $66.4 million (Q4 2024).